Price per Article:
Nonmember - $40
Member - FREE
Credits: 1 CME/CE Credit
Full Accreditation information listed below.
Additional Course Details
Description:
The study aimed to evaluate the feasibility of implementing lifestyle interventions in primary care settings with hypertensive patients and their effect on blood pressure, body composition, cardiometabolic markers, and antihypertensive drug use. Sixty participants diagnosed with stage 1 hypertension were randomly assigned to 4 groups: (1) Standard medical care (control), (2) Physical activity protocol, (3) Dietary Approach to Stop Hypertension (DASH) diet, and (4) Combination of physical activity protocol and DASH diet. Participants received counseling from family physicians, nurses, kinesiologists, and registered dietitians. Various assessments were conducted before (T0) and after (T6) the interventions, including 24-h ambulatory blood pressure monitoring, blood and urine tests, anthropometric measurements, computed tomography to measure adipose tissue, submaximal exercise test to estimate maximal oxygen consumption and health questionnaires. Fifty-one (51) participants (51/57, 89%) completed the program. All interventions reduced blood pressure indices between T0 and T6, except the combined interventions group. Body composition and cardiometabolic parameters were improved in all groups, except for the control group. In total, 28% of participants (7/23) reduced or stopped their antihypertensive medications at T6. The results suggest that structured lifestyle interventions are feasible in primary care and improve blood pressure and cardiometabolic parameters in patients with stage 1 hypertension.
Learning Objectives:
- Describe the dietary and physical activity interventions used to reduce blood pressure
- State the minimum difference in systolic blood pressure (SBP) this study was designed to detect
- Determine which interventions reduced SBP and diastolic blood pressure (DBP)
- Compare the effect of lifestyle interventions on blood pressure in participants who were taking anti-hypertensive medications and those who were not on these medications
Format: This learning activity consists of one AJLM article and one quiz.
Duration: 1 hour
Assessment and Measurement: A score of 80% or higher on the quiz is required to pass the learning activity.
Specifications: This course can be viewed on desktop, tablet or mobile device.
Term of Approval: September 3, 2024 – September 2, 2027
Enrollment: Access to online material is granted through the term of approval which ends September 2, 2027.
Accreditation and Joint Providership Statement:
In support of improving patient care, this activity has been planned and implemented by RUSH University Medical Center and American College of Lifestyle Medicine. RUSH University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statement:
For Medicine: Rush University Medical Center designates enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
For Nursing: Rush University Medical Center designates this enduring material for a maximum of 1.00 nursing contact hour(s).
For Pharmacy: Rush University Medical Center designates this knowledge-based enduring material for a maximum of 1.00 contact hour(s) for pharmacists.
For Psychologists: Rush University Medical Center designates this enduring material for 1.00 CE credits in psychology.
For Dieticians: This enduring material has been approved by the Commission on Dietetic Registration for 1.00 CPEUs.
For Social Work: As a Jointly Accredited Organization, Rush University Medical Center is approved to offer social work continuing education buy the Association of Social Work Boards (ASWB) Approved continuing education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 general continuing education credits.
For physical therapy or occupational therapy: Rush University is an approved provider for physical therapy/occupational therapy by the Illinois Department of Professional Regulation. Rush University designates this enduring material for a maximum of 1.00 continuing education credits for physical therapists/ occupational therapists.
ABLM MOC: The American Board of Lifestyle Medicine has approved 1.0 maintenance of certification credits for this learning activity.
Disclosure Statement:
As a provider of continuing education, Rush University Medical Center asks everyone who has the ability to control or influence the content of an educational activity to disclose information about all of their financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies. Individuals must disclose regardless of their view of the relevance of the relationship to the education. Mechanisms are in place to identify and mitigate any potential conflicts of interest prior to the start of the activity. All information disclosed must be shared with the participants/learners prior to the start of the educational activity.
Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.
Individuals in control of content have disclosed the following:
- Rohit Moghe, PharmD, MSPH, CDCES - Member, Speakers Bureau, Novo Nordisk
All of the relevant financial relationships listed for these individuals have been mitigated. The remaining course director(s), planner(s), faculty, and reviewer(s) of this activity have no relevant financial relationship(s) with ineligible companies to disclose.